/24-7PressRelease/ - MONROVIA, CA, August 21, 2008 - Dr. Herbert Fritsche, Professor and Chief of Clinical Chemistry at MD Anderson Cancer Center in Houston, Texas will give the keynote address entitled "Cancer Biomarkers - Considerations For Discovery, Validation and Implementation" at this year's Biomarker Discovery Europe forum.
Dr. Fritsche's presentation will outline how blood and tissue markers play a key role in the diagnosis and clinical management of cancer. He will discuss how early detection helps improve cure rates and overall survival times of cancer patients. Dr. Fritsche will also cover considerations for implementation of new biomarkers including regulatory approval, peer review of clinical claims, recommendations from clinical practice guidelines committees, cost of testing, reimbursement and routine clinical laboratory operations.
Biomarker Discovery Europe 2008 taking place on October 2-3, 2008 in Dublin, Ireland will create a forum whereby industry leaders from the US, Europe, and Asia can collaborate and explore some of the differences between the US and European R & D environment. New technologies used to expedite the discovery to validation process as well as the usage of biomarkers in clinical trial design will be highlighted. A unique look at the practical issues and concerns with the role of biomarkers in personalized medicine will also be addressed. For more information visit http://gtcbio.com/conferenceDetails.aspx?id=130.
Contact: GTCBIO 434 W. Foothill Blvd. Monrovia, CA 91016 Tel: (626) 256-6405 fax: (626) 256-6460 email: jason.yi@gtcbio.com
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com
# # #
Read more Press Releases from Rania Hafez:- Michael Karin, Professor at UCSD to Give Keynote Speech at 7th Cytokines & Inflammation Conference
- GTCbio Announces its 7th Annual Cytokines & Inflammation Conference
- Samir Hanash, Program Head at the Fred Hutchinson Cancer Research Center to Give Keynote Speech at GTCbio's 2nd Oncology Biomarkers Conference on January 19-20 in Miami, Florida
- GTCbio Announces its 2nd Annual Oncology Biomarkers Conference
- Michael Shih, Director of Business Development at Eisai Inc. and Deepa Talpade, Director of Global Licensing & Strategic Alliances at Schering Plough to Give Joint Featured Presentation at GTCbio's CNS Diseases Partnering & Deal-Making Summit on Dec. 1-2, 2008 in Boston, MA
- GTCBIO ANNOUNCES ITS INAUGURAL CNS DISEASES PARTNERING & DEAL-MAKING SUMMIT
- Johan Luthman, Global Head of Exploratory Medicine Neurology at MerckSerono to Give Plenary Keynote Address at 4th Modern Drug Discovery & Development Summit (Oct. 15-17, 2008 - San Diego, CA)
- Mike Romanos, Vice President of Discovery Technologies at GlaxoSmithKline to Give Keynote Presentation at GTCbio's Biomarker Discovery Europe Conference on October 2-3, 2008 in Dublin, Ireland
- Sharath Hegde, Vice President at Theravance to Give Featured Presentation at GTCbio's Bugs & Drugs Conference on September 22-23, 2008 in San Diego, CA
- Barry Eisenstein, SVP at Cubist Pharmaceuticals to Give Keynote Presentation at GTCbio's Bugs & Drugs Conference on September 22-23, 2008 in San Diego, CA
Other Press Release Headlines:
